Platelet morphology analysis

Methods in Molecular Biology

Volumn 992, Issue , 2013, Pages 207-225

  Latger Cannard, Véronique ^a   Fenneteau, Odile ^b   Salignac, Sylvain ^a   Lecompte, Thomas Pierre ^c   Schlegel, Nicole ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Inherited thrombocytopenia; Morphology; Platelet disorders; Platelets; Thrombocytopenia

Indexed keywords

ANTICOAGULANT AGENT; EDETIC ACID;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ARTICLE; BERNARD SOULIER DISEASE; BLOOD SAMPLING; FECHTNER SYNDROME; GENE MUTATION; GRAY PLATELET SYNDROME; HUMAN; JACOBSEN SYNDROME; MAY HEGGLIN ANOMALY; MEGAKARYOCYTE; MICROSCOPY; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE DISORDER; THROMBOCYTE STRUCTURE; THROMBOCYTE VOLUME; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

EID: 84877153941     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-339-8_16     Document Type: Article

References (38)

1. Levine RF, Olson TA, Shoff PK, Miller MK, Weisman LE (1996) Mature micromegakaryocytes: An unusual developmental pattern in term infants. Br J Haematol 94: 391-399
2. Brière J (1995) Thrombocytémie essentielle. Encycl Med Chir Hématologie 13-020-B-05, p 10.
3. Flandrin G, Lessard M (1991) Syndromes myélodysplasiques. Encycl Med Chir, (Paris-France), Hématologie, 13012 A 10, p 8.
4. Benett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al (1985) Criteria for the diagnosis of acute leukaemia of megakaryocyte lineage. A report of the French-American-British Cooperative Group, Ann Intern Med. 103:460-462.
5. Latger-Cannard V, Sommelet D, Guerci B, Tréchot P, Lecompte T (2001) Platelet gigantism associated with cholestyramine therapy. Arch Intern Med 161:2619-2620
6. Stöckler S, Molzer B, Plecko B, Zen W, Muntean W, Söling U et al (1993) Giant platelets in erucic acid therapy for adrenoleukodystrophy. Lancet 341:1414-1415
7. Balduini CL, Cattaneo M, Fabris F, Gresele P, Iolascon A, Pulcinelli FM, on behalf of the Italian "Gruppo di Studio delle Piastrine" et al (2003) Inherited thrombocytopenias: A proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Platelets 88:582-592
8. Geddis AE, Kaushansky K (2004) Inherited thrombocytopenias: Towards a molecular understanding of disorders of platelet production. Curr Opin Pediatr 16:15-24
9. Nurden AT (2005) Qualitative disorders of platelets and megakaryocytes. J Thromb Haemost 3:1773-1782
10. Nurden P, Nurden AT (2008) Congenital disorders associated with platelet dysfunctions. Thromb Haemost 99:253-263
11. Latger-Cannard V, Salignac S, Salmon A, Mansuy L, de Maistre E, Botte C et al (2005) Thrombocytopenia: Clinicobiologic validation and classification. Ann Biol Clin 63:1-12
12. Drachman JG, Jarvik GP, Mehaffey MG (2000) Autosomal dominant thrombocytopenia: Incomplete megakaryocyte differentiation and linkage to chromosome 10. Blood 96:118-125
13. Pipucci T, Savoia A, Perrotta S, Pujol-Moix N, Noris P, Castegnaro G et al (2011) Mutations in the 5 -UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomaldominant form of inherited thrombocytopenia, THC2. Am J Hum Genet 88:115-120
14. King S, Germeshausen M, Strauss G, Welte K, Ballmaier M (2005) Congenital amegakaryocytic thrombocytopenia: A retrospective clinical analysis of 20 patients. Br J Haematol 131:636-644
15. Greenhalgh K, Howell R, Bottani A, Ancliff P, Brunner H, Verschuuren-Bemelmans C et al (2002) Thrombocytopenia-absent radius syndrome: A clinical genetic study. J Med Genet 39:876-881
16. Béri-Dexheimer M, Latger-Cannard V, Philippe C, Bonnet C, Chambon P et al (2008) Clinical phenotype of germline RUNX1 haploinsuf fi ciency: From point mutations to large genomic deletions. Eur J Hum Genet 16:1014-1018
17. Latger-Cannard V, Proust A, Devignes J, Salignac S, Bensoussan D, Salmon A et al (2008) A Wiskott-Aldrich syndrome revealed by a careful morphological examination of the platelets in a child. Hématologie 14:387-391
18. Latger-Cannard V, Bensoussan D, Grégoire MJ, Marçon F, Cloez JL, Leheup B et al (2004) Frequency of thrombocytopenia and large platelets correlate neither with conotruncal cardiac anomalies nor immunologic features in chromosome 22q11.2 deletion syndrome. Eur J Pediatrics 163:327-328
19. Liang HP, Morel-Kopp MC, Curtin J, Wilson M, Hewson J, Chen W et al (2007) Heterozygous loss of platelet glycoprotein (GP) Ib-V-IX variably affects platelet function in velocardiofacial syndrome (VCFS) patients. Thromb Haemost 98:1298-1308
20. Najean Y, Lecompte T (1990) Genetic thrombocytopenia with autosomal dominant transmission: A review of 54 cases. Br J Haematol 74:203-208
21. Savoia A, Balduini CL, Savino M, Noris P, Del Vecchio M, Perrotta S et al (2001) Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome. Blood 97:1330-1335
22. Ciovacco W, Raskind W, Kacena M (2008) Human phenotypes associated with GATA-1 mutations. Genet 427:1-6
23. Kunishima S, Yoshinari M, Nishio H, Ida K, Miura T, Matsushita T et al (2007) Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations. Eur J Haematol 78:220-226
24. Kunishima S, Matsushita T, Kojima T, Sako M, Kimura F, Jo E-K et al (2003) Immuno fl uorescence analysis of neutrophil Non Muscle Myosin Heavy Chain-A in MYH9 disorders: Association of subcellular localization with MYH9 mutations. Lab Invest 83:115-122
25. Pecci A, Panza E, Pujol-Moix N, Klersy C, Di Bari F, Bozzi V et al (2008) Position of nonmuscle myosin heavy chain IIA mutations predicts the natural history of MYH9-related disease. Hum Mutat 29:409-417
26. Pecci A, Panza E, De Rocco D, Pujol-Moix N, Girotto G, Podda L et al (2009) MYH9 related disease: Four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype. Eur J Haematol 84:291-297
27. Stewart GW, Makris M (2008) Mediterranean macrothrombocytopenia and phytosterolaemia/sitosterolaemia. Haematologica 93:e29
28. Rees DC, Iolascon A, Carella M, O'marcaigh AS, Kendra JR, Jowitt SN et al (2005) Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia. Br J Haematol 130:297-309
29. Nurden P, Debili N, Vainchenker W, Bobe R, Bredoux R, Corvazier E et al (2006) Impaired megakaryocytopoiesis in type 2B Willebrand disease with severe thrombocytopenia. Blood 108:2587-2595
30. Thompson AA, Nguyen LT (2000) Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation. Nat Genet 26:397-398
31. Nurden AT, Nurden P (2007) The gray platelet syndrome: Clinical spectrum of the disease. Blood Rev 21:21-36
32. Gunay-Agun M, Falik-Zaccai TC, Vilboux T, Zivony-Elboum Y, Gumruk F, Cetin M et al (2011) NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet alpha-granules. Nat Genet 43:732-734
33. Fabbro S, Hinckley J, Li L, Schwertz H, Christensen H, Rowley JW et al (2011) Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet 43:738-740
34. Albers CA, Cvejic A, Favier R, Bouwmans EE, Alessi MC, Bertone P et al (2011) Exome sequencing identi fi es NBEAL2 gene as the causative gene for gray platelet syndrome. Nat Genet 43:735-737
35. Jacobsen P, Hauge M, Henningsen K (1973) An (11;21) translocation in four generation with chromosome 11 abnormalities in the offspring. A clinical, cytogenetical and gene marker study. Hum Hered 23:568-585
36. Favier R, Jondeau K, Boutard P, Grossfeld P, Reinert P, Jones C et al (2003) Paris-Trousseau syndrome: Clinical, hematological, molecular data of ten new cases. Thromb Haemost 90:893-897
37. Breton-Gorius J, Favier R, Guichard J, Cherif D, Berger R, Debili N et al (1995) New congenital dysmegakaryopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet alpha-granules and chromosome 11 deletion at 11q23. Blood 85:1805-114
38. Valduga M, Latger-Cannard V, Philippe C, Romana S, Miton A, Droulle P et al (2007) Prenatal diagnosis of mosaïcism for 11q terminal deletion. Eur J Med Genet 50: 475-481